DMH1

• 产品号: D8946
• CAS号: 1206711-16-1
• 分子式: C24H20N4O
• 分子量: 380.4418
• 纯 度: ≥98% (HPLC)
• 保 存: desiccated

产品别名

• 标题: DMH1
• IUPAC标准名: 4-{6-[4-(propan-2-yloxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl}quinoline
• IUPAC传统名: 4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
• 别名: 4-[6-(4-Isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline; 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline

产品登记号

• MDL号: MFCD18384963
• CAS号: 1206711-16-1

产品性质

• Empirical Formula (Hill Notation): C24H20N4O
• 纯度: ≥98% (HPLC)
• 外观: light yellow to orange powder
• 溶解度: DMSO: soluble5 mg/mL, clear (warmed)
• GHS警示词: Danger
• GHS危险声明: H301
• 欧盟危险性物质标志: 有毒(Toxic) (T)
• GHS警示性声明: P301 + P310
• 危险公开号: 25
• 安全公开号: 45
• 保存条件: desiccated
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
DMH1 is a highly selective Bone morphogenetic protein (BMP) inhibitor. DMH1 is a dorsomorphin analogue that exclusively targets the BMP but not the VEGF pathway.

详细说明 (简体中文)

Biochem/physiol Actions
DMH1 is a highly selective Bone morphogenetic protein (BMP) inhibitor. DMH1 is a dorsomorphin analogue that exclusively targets the BMP but not the VEGF pathway.